First Capital Advisors Group, Llc. Abb Vie Inc. Transaction History
First Capital Advisors Group, Llc.
- $188 Million
- Q2 2023
A detailed history of First Capital Advisors Group, Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 2,140 shares of ABBV stock, worth $421,194. This represents 0.15% of its overall portfolio holdings.
Number of Shares
2,140
Previous 2,156
0.74%
Holding current value
$421,194
Previous $343,000
16.03%
% of portfolio
0.15%
Previous 0.22%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
3,696Shares Held
1.27BCall Options Held
13MPut Options Held
9.79M-
Vanguard Group Inc Valley Forge, PA171MShares$33.6 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.3 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.5 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.6 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $348B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...